Original Research

Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Author and Disclosure Information

A multicenter, randomized, vehicle-controlled, 3-week study was conducted in patients with chronic hand dermatitis (HD) of various etiologies and locations to identify subgroups particularly responsive to twice-daily application of pimecrolimus cream 1% with overnight occlusion. A total of 294 patients were randomized to the study. By the final visit on day 22, there was a trend toward greater clearance in patients who received pimecrolimus than in those treated with vehicle cream. An analysis of treatment success by various stratification factors were performed, and it was found that palmar involvement had notable impact on response (P=.033). Patients in the pimecrolimus group continued to improve throughout the study; however, in the vehicle group, improvement plateaued after 15 days. Pimecrolimus was well tolerated, with a low rate of application-site reactions such as burning. Pimecrolimus cream 1%, when used twice daily with overnight occlusion, may be of benefit in the management of chronic HD.


 

Recommended Reading

Skin Reaction Following Immunization With Smallpox Vaccine: A Personal Perspective
MDedge Dermatology
Pet Hamsters as a Source of Rat Mite Dermatitis
MDedge Dermatology
Trachyonychia: A Case Report and Review of Manifestations, Associations, and Treatments
MDedge Dermatology
Botanical Briefs: Tulips—Tulipa Species L.
MDedge Dermatology
What's Eating You? Megalopyge opercularis
MDedge Dermatology
Combination Therapy of Tetracycline and Tacrolimus Resulting in Rapid Resolution of Steroid-Induced Periocular Rosacea
MDedge Dermatology
Clocortolone Pivalate Cream 0.1% Used Concomitantly With Tacrolimus Ointment 0.1% in Atopic Dermatitis
MDedge Dermatology
Problem Pets [editorial]
MDedge Dermatology
Botanical Briefs: The Century Plant—Agave americana L.
MDedge Dermatology
Bullous Contact Dermatitis Caused by Self-Applied Crushed Paederus fuscipes for the Treatment of Vitiligo
MDedge Dermatology